Top Markets
Coin of the day
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Rank in Stocks #40859
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Share Price
$0.00312742
Last synced: 2024-10-01
Market Cap
$70.81K
Change (1 day)
-21.83%
Change (1 year)
0.00%
Country
SE
Trade Asarina Pharma AB (publ) (ASAP)

Category

Earnings for Asarina Pharma AB (publ) (ASAP)
Earnings in Dec 2023 TTM: $-1.45M
According to Asarina Pharma AB (publ) latest financial reports the company's current earnings are $-1.45M. In 2022 the company made an earning of $-1.42M, an increase over its 2021 earnings that were of $-4.23M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Asarina Pharma AB (publ) from 2017 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-1.45M 0.00%
2023 $-1.45M 1.62%
2022 $-1.42M -66.40%
2021 $-4.23M -57.86%
2020 $-10.04M 18.85%
2019 $-8.45M 46.31%
2018 $-5.78M 46.17%
2017 $-3.95M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -365,136.62%
US
$1.95B -135,090.00%
NL
- -
CH
- -
KR
$3.01B -208,103.35%
BE